about
The Current State of Clinical Application of Serum Biomarkers for Canine LymphomaSerum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult diseaseThe immunosignature of canine lymphoma: characterization and diagnostic applicationA New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy.
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Thymidine kinase assay in canine lymphoma.
@ast
Thymidine kinase assay in canine lymphoma.
@en
Thymidine kinase assay in canine lymphoma.
@nl
type
label
Thymidine kinase assay in canine lymphoma.
@ast
Thymidine kinase assay in canine lymphoma.
@en
Thymidine kinase assay in canine lymphoma.
@nl
prefLabel
Thymidine kinase assay in canine lymphoma.
@ast
Thymidine kinase assay in canine lymphoma.
@en
Thymidine kinase assay in canine lymphoma.
@nl
P2093
P2860
P1476
Thymidine kinase assay in canine lymphoma.
@en
P2093
J W Elliott
L Blackwood
P2860
P356
10.1111/J.1476-5829.2011.00296.X
P577
2011-12-08T00:00:00Z